Carnrite Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Form Bioformbio.comin𝕏Sep 2022
Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.
AI & Machine LearningBiotechDeep TechAustin, US
Benjamin Lamm(Director, Promoter)Andrew Busey(Executive Officer, Director, Promoter)Michelle Chen, PhDDoug DanielsJoe Nipko, PhDAmicia Elliott, PhD
Co-investorsBold Capital PartnersBreyer CapitalDraper AssociatesJAZZ Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.